48
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Non‐fibrillar β‐amyloid exerts toxic effect on neuronal cells

&
Pages 139-143 | Received 03 Mar 2001, Accepted 09 Apr 2001, Published online: 22 Nov 2010
 

Alzheimer's disease is the most common form of dementia and no cure is known so far. Extensive genetic works and in vitro experiments combined with clinical observations link amyloid β‐protein (Aβ) to the pathogenesis of Alzheimer's disease (AD). It was hypothesized that Aβ becomes toxic when it adopts a fibrillar conformation. Recently, non‐fibrillar form of Aβ was observed and the potential role in the pathogenesis of AD became an interesting subject. In this study, the cytotoxicity of non‐fibrillar Aβ and fibrillar Aβ was compared on oxidative stress, membrane damage, or nucleosome break down. Non‐fibrillar Aβ was not toxic in peripheral nervous system‐derived cells but significantly toxic in central nervous system‐derived cells while fibrillar Aβ was non‐selectively toxic in both cell culture. The neurotoxicity of non‐fibrillar Aβ was reproduced in semi‐in vivo culture of mouse brain slice. In conclusion, non‐fibrillar Aβ could be more relevant to the selective neurodegeneration in Alzheimer's brains than fibrillar Aβ and further research needs to be done for identification of the cause of AD.

Notes

To whom correspondence should be addressed. Tel: 82–63–270–3105, Fax: 82–63–270–3930, E‐mail: [email protected]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.